Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 COMPONENT SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF GENE THERAPY
6.1.3 EXPANSION OF SYNTHETIC BIOLOGY
6.1.4 RISING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY
6.2 RESTRAINTS
6.2.1 LACK OF TRAINED PROFESSIONALS
6.2.2 ETHICAL ISSUES
6.2.3 LONG APPROVAL PROCESS
6.3 OPPORTUNITIES
6.3.1 RISE IN HEALTHCARE EXPENDITURE
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS
6.3.3 RISING DEMAND FOR CUSTOMIZED MEDICATIONS
6.4 CHALLENGES
6.4.1 TECHNICAL LIMITATIONS ACROSS PRODUCTION PROCESS
6.4.2 LACK OF WELL DEFINED PATENT SYSTEM
7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SOFTWARE & SERVICES
7.3 CONSUMABLES
7.3.1 REAGENTS
7.3.2 ASSAYS
7.3.3 PROBES & DYES
7.3.4 OTHERS
7.4 SYNTHESIZER
7.4.1 COLUMN-BASED SYNTHESIZERS
7.4.2 MICROARRAY-BASED SYNTHESIZERS
8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE
8.1 OVERVIEW
8.2 STANDARD GENE
8.3 COMPLEX GENE
8.4 EXPRESS GENE
8.5 OTHERS
9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE
9.1 OVERVIEW
9.2 CUSTOM GENE SYNTHESIS
9.2.1 STANDARD GENE
9.2.2 COMPLEX GENE
9.2.3 EXPRESS GENE
9.2.4 OTHERS
9.3 GENE LIBRARY SYNTHESIS
9.3.1 STANDARD GENE
9.3.2 COMPLEX GENE
9.3.3 EXPRESS GENE
9.3.4 OTHERS
10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 SYNTHETIC BIOLOGY
10.2.1 CUSTOM GENE SYNTHESIS
10.2.2 GENE LIBRARY SYNTHESIS
10.3 GENETIC ENGINEERING
10.3.1 CUSTOM GENE SYNTHESIS
10.3.2 GENE LIBRARY SYNTHESIS
10.4 THERAPEUTIC ANTIBODIES
10.4.1 CUSTOM GENE SYNTHESIS
10.4.2 GENE LIBRARY SYNTHESIS
10.5 VACCINE DESIGN
10.5.1 CUSTOM GENE SYNTHESIS
10.5.2 GENE LIBRARY SYNTHESIS
10.6 OTHERS
11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD
11.1 OVERVIEW
11.2 PCR-BASED ENZYME SYNTHESIS
11.3 CHIP-BASED DNA SYNTHESIS
11.4 SOLID BASED SYNTHESIS
12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER
12.1 OVERVIEW
12.2 ACADEMIC & RESEARCH INSTITUTE
12.3 BIOTECH & PHARMACEUTICAL COMPANIES
12.4 DIAGNOSTIC LABORATORIES
12.5 OTHERS
13 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 ONLINE DISTRIBUTION
13.4 THIRD PARTY DISTRIBUTORS
14 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY REGION
14.1 MIDDLE EAST &AFRICA
14.1.1 SAUDI ARABIA
14.1.2 SOUTH AFRICA
14.1.3 U.A.E.
14.1.4 ISRAEL
14.1.5 EGYPT
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER)
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 THERMO FISHER SCIENTIFIC INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 EUROFINS SCIENTIFIC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 SERVICE PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 MERCK KGAA
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KANEKA EUROGENTEC S.A.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 ANSA BIOTECHNOLOGIES, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ATD BIO LTD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 ATG:BIOSYNTHETICS GMBH
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 AZENTUS US, INC (2021)
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 BBI LIFESCIENCES CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 BIO BASIC INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 BIOCAT GMBH
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 BIONEER PACIFIC
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 BOSTER BIOLOGICAL TECHNOLOGY
17.14.1 COMPANY SNAPSHOT
17.14.2 SERVICE PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 CSBIO
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 CREATIVE BIOGENE
17.16.1 COMPANY SNAPSHOT
17.16.2 RODUCTPORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 EVONETIX
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 EXONBIO
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 GCC BIOTECH (INDIA) PVT. LTD.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 GINKGO BIOWORKS (2021)
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 GENERAL BIOSYSTEMS INC
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 GENSCRIPT
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 MACROGEN CO., LTD. (A SUBSIDIARY OF MACROGEN, INC)
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 NZYTECH, LDA. - GENES AND ENZYMES.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 ORIGENE TECHNOLOGIES, INC
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENTS
17.26 PROMAB BIOTECHNOLOGIES
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 PROTEOGENIX
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 SYNBIO TECHNOLOGIES
17.28.1 COMPANY SNAPSHOT
17.28.2 PRODUCT PORTFOLIO
17.28.3 RECENT DEVELOPMENTS
17.29 TRENZYME GMBH
17.29.1 COMPANY SNAPSHOT
17.29.2 PRODUCT PORTFOLIO
17.29.3 RECENT DEVELOPMENTS
17.3 TWIST BIOSCIENCE
17.30.1 COMPANY SNAPSHOT
17.30.2 REVENUE ANALYSIS
17.30.3 PRODUCT PORTFOLIO
17.30.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 57 SAUDI ARABIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 SAUDI ARABIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 60 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 61 SAUDI ARABIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 62 SAUDI ARABIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 63 SAUDI ARABIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 SAUDI ARABIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 65 SAUDI ARABIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 66 SAUDI ARABIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 67 SAUDI ARABIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 68 SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 69 SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 SAUDI ARABIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 72 SOUTH AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 SOUTH AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 75 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 76 SOUTH AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 77 SOUTH AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 78 SOUTH AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 79 SOUTH AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 81 SOUTH AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 82 SOUTH AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 83 SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 84 SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 SOUTH AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 U.A.E GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 87 U.A.E CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 U.A.E SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 U.A.E GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 90 U.A.E GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 91 U.A.E CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 92 U.A.E GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 93 U.A.E GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 94 U.A.E SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 95 U.A.E GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 96 U.A.E THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 97 U.A.E VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 98 U.A.E GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 99 U.A.E GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 100 U.A.E GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 101 ISRAEL GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 102 ISRAEL CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 ISRAEL SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 ISRAEL GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 105 ISRAEL GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 106 ISRAEL CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 107 ISRAEL GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 108 ISRAEL GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 ISRAEL SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 110 ISRAEL GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 111 ISRAEL THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 112 ISRAEL VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 113 ISRAEL GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 114 ISRAEL GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 115 ISRAEL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 116 EGYPT GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 117 EGYPT CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 118 EGYPT SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 119 EGYPT GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 120 EGYPT GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 121 EGYPT CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 122 EGYPT GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 123 EGYPT GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 124 EGYPT SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 125 EGYPT GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 126 EGYPT THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 127 EGYPT VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 128 EGYPT GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 129 EGYPT GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 130 EGYPT GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 131 REST OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DATA TRIANGULATION
FIGURE 4 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT
FIGURE 5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BOTTOM UP APPROACH
FIGURE 6 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: TOP DOWN APPROACH
FIGURE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SEGMENTATION
FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
FIGURE 16 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2021
FIGURE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 19 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2021
FIGURE 21 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029)
FIGURE 23 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021
FIGURE 25 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029)
FIGURE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2021
FIGURE 29 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2021
FIGURE 33 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 34 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 35 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021
FIGURE 37 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION)
FIGURE 38 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 39 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 42 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 43 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2021)
FIGURE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021)
FIGURE 46 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 47 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029)
FIGURE 49 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%)
